跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,750 条关于
“immunomodulatory agent”
全部
7,750
临床试验
4,359
药物
669
机构
21
资讯
2,701
8年前
GSK's BCMA-Targeting ADC, GSK2857916, Receives FDA Breakthrough Therapy Designation for Multiple Myeloma
去年
FDA Places Clinical Hold on Rocket Pharmaceuticals' Gene Therapy Trial After Patient Death
9个月前
CARVYKTI Shows Durable Treatment-Free Remissions at 2.5 Years in Earlier-Line Multiple Myeloma
2年前
FDA Approves CAR-T Therapies Abecma and Carvykti for Earlier Use in Multiple Myeloma
9个月前
Attivare Therapeutics Secures $6.6 Million Gates Foundation Grant for Next-Generation Malaria Vaccine
3年前
GSK's Belantamab Mafodotin Expands Development Portfolio to Target Diffuse Large B-Cell Lymphoma
2年前
CAR-T Therapies Gain Ground in China and Beyond: Regulatory Approvals and Clinical Advancements
去年
Health Canada Approves J&J's CARVYKTI as Early as Second-Line Treatment for Multiple Myeloma
去年
Celgene’s Multiple Myeloma Orphan Drug Gets FDA Approval
2年前
NHS Scotland Approves Elranatamab and Teclistamab for Relapsed/Refractory Multiple Myeloma
第 1 页,共 271 页
上一页
下一页